Biofil Chemicals (India) Investor Sentiment

BIOFILCHEM   41.16  1.27  2.99%   
About 62% of Biofil Chemicals' investor base is looking to short. The analysis of overall sentiment of trading Biofil Chemicals Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Biofil Chemicals' historical and current headlines, can help investors time the market. In addition, many technical investors use Biofil Chemicals Pha stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Biofil Chemicals Faces Significant Volatility Amid Broader Market Resilience - MarketsMojo
Google News at Macroaxis
over three weeks ago at news.google.com         
Biofil Chemicals Hits 52-Week Low Amid Ongoing Industry Challenges and Declining Performance - Marke...
Google News at Macroaxis
over a month ago at news.google.com         
Biofil Chemicals Hits 52-Week Low Amid Broader Market Resilience Challenges - MarketsMojo
Google News at Macroaxis
over a month ago at news.google.com         
Biofil Chem Standalone December 2024 Net Sales at Rs 14.20 crore, up 182.13 percent Y-o-Y - Moneycon...
Google News at Macroaxis
over a month ago at news.google.com         
Biofil Chemicals and Pharmaceuticals Third Quarter 2025 Earnings EPS 0.10 - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
One Global Service Provider standalone net profit rises 138.36 percent in the December 2024 quarter ...
Google News at Macroaxis
over two months ago at news.google.com         
Biofil Chemicals Hits 52-Week Low Amid Ongoing Performance Challenges in Pharmaceuticals Sector - Ma...
Google News at Macroaxis
over two months ago at news.google.com         
Biofil Chemicals Pharmaceuticals standalone net profit rises 19.05 percent in the March 2024 quarter...
Google News at Macroaxis
over two months ago at news.google.com         
Biofil Chemicals Hits 52-Week Low Amid Broader Sector Challenges - MarketsMojo
Google News at Macroaxis
over three months ago at news.google.com         
The Trend Of High Returns At Indraprastha Medical Has Us Very Interested - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Biofil Chemicals and Pharmaceuticals Limiteds Stock Is Rallying But Financials Look Ambiguous Will T...
Google News at Macroaxis
over three months ago at news.google.com         
Biofil Chem Standalone September 2024 Net Sales at Rs 2.41 crore, down 86.11 percent Y-o-Y - Moneyco...
Google News at Macroaxis
over three months ago at news.google.com         
Biofil Chemicals Pharmaceuticals Reports Flat Performance in Q2 2024, Operating Cash Flow Remains St...
Google News at Macroaxis
over three months ago at news.google.com         
Tirupati Forge standalone net profit rises 72.55 percent in the September 2024 quarter - Business St...
Google News at Macroaxis
over three months ago at news.google.com         
Biofil Chemicals Pharmaceuticals standalone net profit declines 83.33 percent in the September 2024 ...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Biofil Chemicals that are available to investors today. That information is available publicly through Biofil media outlets and privately through word of mouth or via Biofil internal channels. However, regardless of the origin, that massive amount of Biofil data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biofil Chemicals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biofil Chemicals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biofil Chemicals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biofil Chemicals alpha.

Biofil Chemicals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Biofil Chemicals Hits 52-Week Low Amid Ongoing Performance Challenges in Pharmaceuticals Sector - MarketsMojo
01/27/2025
2
Biofil Chem Standalone December 2024 Net Sales at Rs 14.20 crore, up 182.13 percent Y-o-Y - Moneycontrol
02/17/2025
3
Biofil Chemicals Faces Significant Volatility Amid Broader Market Resilience - MarketsMojo
03/17/2025

Complementary Tools for Biofil Stock analysis

When running Biofil Chemicals' price analysis, check to measure Biofil Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofil Chemicals is operating at the current time. Most of Biofil Chemicals' value examination focuses on studying past and present price action to predict the probability of Biofil Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofil Chemicals' price. Additionally, you may evaluate how the addition of Biofil Chemicals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments